Other mouse models have also demonstrated that Lactobacillus acidophilus can improve anti-CTLA4 therapeutic efficacy in CRC by reducing Treg cells and “M2” TAM and by increasing CD8+ T cells (59). The gene discussed is CTLA4; the disease is colorectal carcinoma.